Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1AGALSIDASE BETA
(D03228)		1件: Agalsidase beta1件: Agalsidase beta (D03228) 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
2Agalsidase beta (GZ419828)
(D03228)		1件: Agalsidase beta1件: Agalsidase beta (D03228) 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
3Agalsidase beta (recombinant form)
(D03228)		1件: Agalsidase beta1件: Agalsidase beta (D03228) 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
4Agalsidase beta from Biosidus 1 mg/kg
(D03228)		1件: Agalsidase beta1件: Agalsidase beta (D03228) 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
5Fabrazyme (agalsidase beta)
(D03228)		1件: Agalsidase beta1件: Agalsidase beta (D03228) 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
6Fabrazyme (agalsidase beta) 1 mg/kg
(D03228)		1件: Agalsidase beta1件: Agalsidase beta (D03228) 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬